Alia Therapeutics

Keywords

  • Biotech
  • Health
  • life sciences
  • Medtech

Industries

Biotech

Abstract

Leveraging on its proprietary technology, Alia Therapeutics, the first Italian CRISPR company, is developing new therapeutic approaches to treat genetic diseases once considered incurable. Alia’s unique CRISPR-based genome editing tools allow unprecedented specificity in modifying the genome, coupled with safe and efficient delivery into target cells.

Info

Antonio Casini
www aliatherapeutics com